Preparing for the launch of a SARS COV 2 serologic test in Q1 2021.

Following the recent launch of its SARS COV2 ANTIGEN test, AVALUN is now preparing for the launch of a serologic test for the first quarter of 2021. In order to be able to perform this additional test on top of the SARS COV 2 ANTIGEN test and PT/INR, customers already equipped with a LabPad® Evolution will just need to upgrade the software of their device online by connecting to AVALUN’s support center.

Following the SARS COV2 serologic test, AVALUN will concentrate its efforts on nutrition and cardiac markers.